| 1 |
26936914 | ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. | 2016 Jul 15 |
1 |
| 2 |
25871401 | Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer. | 2015 Apr 20 |
2 |
| 3 |
18334972 | Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells. | 2008 Mar 25 |
2 |
| 4 |
15755991 | Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth. | 2005 Mar 1 |
1 |
| 5 |
15833875 | Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer. | 2005 Apr 15 |
2 |